Michelangelo Fiorentino appointed Associate Professor in Clinical Pathology at the University of Bologna
May 22, 2017

Congratulations to Michelangelo Fiorentino, who was recently appointed Associate Professor of Clinical Pathology at the University of Bologna! Following are some of his publications from the past two years, as well as recently funded grants:

  1. Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, Vasuri F, Malvi D, Fornari A, Bonetti LR, Corti B, Papotti M, DeGiuli P, Loda M, Montironi R, Fiorentino M, Rider JR. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer. Virchows Arch. 2017 Apr 12. doi: 10.1007/s00428-017-2123-1. [Epub ahead of print] PubMed PMID: 28405833.
  2. Ciccarese C, Massari F, Iacovelli R, Fiorentino M, Montironi R, Di Nunno V, Giunchi F, Brunelli M, Tortora G. Prostate cancer heterogeneity: Discovering novel molecular targets for therapy. Cancer Treat Rev. 2017 Mar;54:68-73. doi: 10.1016/j.ctrv.2017.02.001. Epub 2017 Feb 11. Review. PubMed PMID: 28231559.
  3. Fiorentino M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R. Considerations for standardizing predictive molecular pathology for cancer prognosis. Expert Rev Mol Diagn. 2017 Jan;17(1):47-55. Epub 2016 Dec 9. PubMed PMID: 27897454.
  4. Ceci F, Fiorentino M, Castellucci P, Fanti S. Molecular Imaging and Precision Medicine in Prostate Cancer. PET Clin. 2017 Jan;12(1):83-92. doi: 10.1016/j.cpet.2016.08.004. Epub 2016 Sep 9. Review. PubMed PMID: 27863569.
  5. Modena A, Ciccarese C, Iacovelli R, Brunelli M, Montironi R, Fiorentino M, Tortora G, Massari F. Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? Oncol Rev. 2016 Apr 15;10(1):293. doi: 10.4081/oncol.2016.293. eCollection 2016 Apr 15. Review. PubMed PMID: 27471580; PubMed Central PMCID: PMC4943092.


18F-FACBC PET/CT for staging high risk prostate cancer

Regione Emilia-Romagna, Progetti Universita’- Regione

Collaborator, € 27.368


Use of biomarkers and gene expression profiles to identify cancer patients with different prognosis and sensitivity to molecular targeted agents

Regione Emilia-Romagna, Progetti Universita’-Regione

Collaborator, € 33.000